TL;DR
Portland anchors the Oregon biotech cluster centered on Oregon Health & Science University (OHSU) spinouts, the Knight Cancer Institute, and the broader Oregon Bioscience Association operator network. The cluster has a strong cancer biotech focus, with insurance characteristics following standard clinical-stage architecture and Oregon-specific regulatory overlay.
Portland biotech
Portland biotech insurance - OHSU spinouts, Knight Cancer Institute, Oregon Bioscience.
Portland anchors the Oregon biotech cluster centered on Oregon Health & Science University (OHSU) - one of the leading West Coast biomedical research institutions outside the Bay Area - and the OHSU Knight Cancer Institute. The cluster contributes spinouts across cancer biotech, immunology, and precision medicine programs.
Cluster characteristics
OHSU and Knight Cancer Institute anchor the cluster.
OHSU spinouts follow standard clinical-stage biotech architecture: D&O for VC-backed governance, clinical trial liability for active studies, IP/E&O for OHSU Technology Transfer office licensing arrangements.
Knight Cancer Institute contributes cancer biotech spinouts with strong precision medicine and early-cancer-detection focus, in addition to traditional immuno-oncology and CAR-T operators.
Oregon Bioscience Association network operators run lean insurance programs at early-stage, scaling at funding rounds.
Portland biotech coverage review